The assay is intended to aid in the diagnosis of and identification of carriers for spinal muscular atrophy (SMA) AUSTIN, Texas–(BUSINESS WIRE)– Asuragen, Inc., a
Gaithersburg, MD, and Vancouver, Canada – Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of the
Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative
MOUNTAIN VIEW, California, June 2, 2020 – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease (NIAID) has awarded a second
– CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology – Precision NanoSystems will lead RNA vaccine formulation development – CanSinoBIO will lead
Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the
MADISON, WI–Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro
MADISON, WI, USA and Malmö, SE — Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop, and commercialize diagnostic tests based
Vancouver BC, April 8, 2020 Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of Dr. Andrew Geall as the
Dynex’s portfolio of open, automated microplate instruments, with a global distribution network and footprint, demonstrates ability to support COVID-19 testing worldwide. CHANTILLY, VA March 27,